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ABSTRACT
Recent studies suggested that several potential genes may explain athletic 
success. However, while genetic assessment will probably become part 
of future talent identifi cation, at present, genetic testing predictive value 
is poor, mainly because athletic success depends on a combination of 
genetic, physiological, behavioral and environmental factors (including 
coaching, medical, nutritional, psychological, equipment, facilities and 
administrative aspects). However, one should consider genetic testing 
not only for talent identifi cation or sport event selection, but also for pos-
sible assistance in the training process itself. In the present case study we 
show an example of potential practical use of genetic profi le assessment 
for improving the athletic training process. We deliberately chose a case 
study of a national-level athlete to show that genetic aid should not be 
limited to top world-class athletes. 
Keywords: genetic profi le, athletic success, training process, individualized 
training regimen
INTRODUCTION
Recent studies attempted to identify genetic variants associated with elite 
athletic performance. These studies relied primarily on the candidate gene 
approach and on single nucleotide polymorphism associations with elite and 
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world class performance using frequently small sample size cohorts from 
different ethnic or geographic areas. However, while several genes have been 
found to potentially explain athletic success, and while genetic assessment 
will probably become part of future talent identification, genetic testing pre-
dictive value is poor at the present time [30]. 
It is now well known that athletic success depends on a combination of 
physiological, behavioral and environmental factors. Thus, genetic endow-
ment is only one of several contributors for elite performance. Genetic coun-
seling is yet a piece in the puzzle of athletic excellence together with coach-
ing, physiological, medical, nutritional, psychological, equipment, facilities 
and administrative aspects. However, one should consider genetic testing 
not only for talent identification or sport event selection, but also for pos-
sible assistance in the training process itself (e.g. genetic explanation for 
specific training type difficulties).
The aim of the present case study was to give an example of potential 
practical use of genetic profile assessment for improving athletic training 
process. Since genetic profiling in the present case study was performed 
many years after the end of the athlete’s career, findings could only give ret-
rospective explanations for unique training process issues and limitations, 
and raise concerns of appropriate athletic specialty selection. We deliberately 
chose a case study of national-level athlete to show that genetic aid should 
not be limited to top world-class athletes. 
Case presentation
A.E. started to train in his high school track & field team at the age of 14. 
Training during the first two years (9th and 10th grade) was performed 3 
times per week. Training from September through December in each of 
these years was devoted to long-distance running (about 60% of the time) 
and different types of interval training (ranging from 150 to 400 m repeti-
tions, about 40% of the time). During January to mid-February the school 
participated in a national cross country relay competition (running dis-
tances: 1000–1500 m). Therefore, training at that time included more intense 
interval training (50% of the time), speed training (30% of the time) and the 
development of general athletic skills (20% of time). From mid-February 
to the end of June, the school prepared for the district and for the national 
track & field championships. Since he also had the best school results for his 
age in 100 m sprint and long-jump, training at that time was more specific 
and focused on running and jumping technique, including improvement 
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of starts and run-up to the jumping board. By the end of the 10th grade he 
won the under 18 district championships in the 400 m run, and was sec-
ond in the national under 16 championships in 400 m run (51.5 sec).  
Due to the success in the 400 m run, his high-school coaches decided to 
focus more on this event in the 11th and 12th grade. However, the training 
program remained relatively similar including high-volume moderate-inten-
sity endurance training during September to December but without partici-
pation in the cross-country competitions, increasing anaerobic endurance 
training as well as training intensity in January to mid-February towards the 
relay cross-country competitions, and more specific training until the end 
of school year during the preparation to the track & field championships. By 
the end of the 11th grade he was ranked second in the country (for under 19) 
in the 400 m run (50.12 sec). Although the training program skeleton in the 
12th grade remained unchanged, due to the final academic examinations, the 
training load was reduced substantially from March (in particularly training 
frequency and intensity). Despite that on February he set the school record 
in a traditional 1080 m around school cross-country track run (2.56 min), a 
record still unbroken to date (35 years later). On May of that year he won the 
national school heptathlon competition (100 m, shot-put, high-jump, long-
jump, 800 m), the national high-school 100 m title (10.7 sec, non-electronic 
time), and during late June and early July he won the national under 19 title 
in the 400 m run and broke the Israeli record (48.53 sec).
In the following three years (age 18 to 21) the athlete and his coaches 
concentrated on the 400 m run, increasing training volume, frequency and 
intensity (6–8 training sessions/week, about 15% endurance, 40% anaerobic 
endurance, 30% speed, 15% resistance) significantly. Each of these years was 
characterized by a very comfortable initial part of the season (character-
ized by relatively more endurance training, with high-volume and moderate 
intensity) with running times that were close to the personal best in the first 
and second 400 m runs during the winter (at that time in Israel, training was 
planned for a single peak in the summer). Therefore, the conclusion of the 
preparatory part of training was accompanied by a very optimistic feeling 
for significant improvements by the end of the season. However, in each 
of these years, when training shifted to become more intense (e.g. intense 
anaerobic endurance type-training including interval sessions of 200–500 
m at 80–90% of maximal speed), the athlete was unable to keep-up and to 
complete the training program in the majority of training sessions. This 
mandated eventually a marked reduction in training intensity up to com-
plete rest and required a very gradual return to practice for a period that 
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lasted between 4 to 6 weeks. Another training feature was that although the 
athlete’s resistance training was light to moderate at most, and consisted of 
only 15% of training time, he experienced confound delayed onset muscle 
soreness following resistance training sessions. These three training seasons 
presented almost a complete stagnation in his personal best result in the 
400 m run (only minor improvement – from 48.53 to 48.42 sec). Due to the 
ability to better tolerate endurance-type training, and to the fact that his 100 
m best result was not so fast, the athlete was advised several times during 
these years by his coaches to change training focus and to try to specialize 
in middle-distance runs (i.e. 800 m). However, despite the coaches’ recom-
mendations, he refused to make this change claiming that he will not be able 
to tolerate training for these events and to compete successfully. 
After these years, at the age of 22, the athlete joined medical school, 
reduced his training markedly and did not compete at all for two years. 
During the third year of medical school he decided to start training again. 
Training consisted of about 20% endurance, 35% anaerobic endurance, 30% 
speed and 15% resistance. However, due to academic obligations, training 
frequency was reduced to an average of 5 sessions a week (in opposed to 6–8 
sessions in previous years). In addition, at that year during the spring, train-
ing intensity was also reduced, and the number of super-intense anaerobic 
endurance training sessions was limited. Resistance training intensity was 
also reduced (not more than 70% of 1RM). Unexpectedly, given the nature 
of his training at that period, in his first 400 m run at that season he broke 
his personal best time (48.29 sec). In addition, by the end of the season 
he won the 400 m run national championships and broke again the Israeli 
national record (47.79 sec), improving his personal best time by more than 
half a second).
Twenty five years later we evaluated the genetic profiles of Israeli all-
timers speed/power and endurance athletes [7, 14, 15]. As part of this evalu-
ation, A.E.’s genetic profile was analyzed as well. By combining his specific 
genetic profile assessment with the detailed history of his athletic training 
and career, the present case study may demonstrate how the analysis of this 
profile could be used to better understand training responses and perfor-
mance capabilities. Such preliminary knowledge may direct coaches in cre-
ating an appropriate personalized training program, one that considers the 
unique genetic profile of the individual. 
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Genetic profile
We computed the combined influence of five power-speed and five endur-
ance polymorphisms following a model used elsewhere in order to cre-
ate power and endurance genetic distance scores (PGDF5 and EGDF5, 
respectively). First, we scored each genotype within each polymorphism. 
We assumed an additive model (equaling 0, 1 or 2), based on the number 
of alleles associated with a higher potential for power-speed or endurance 
performance of the athlete for each polymorphism. Thus, we assigned a 
genotype score (GS) of 2, 1 and 0 to each individual genotype, theoretically 
associated with the highest, medium, or lowest potential for power-speed or 
endurance performance, respectively. PGDS5 was calculated by computing 
the combined influence of the 5 polymorphisms (ACE I/D, ACTN3 C/T, 
IL6 –174 G/C, NOS3 T/C, AGTM/T, detailed in Table 1) [32]. PGDS5 equals 
the Euclidean distance from the perfect endurance genetic score for each 
polymorphism, and was transformed into a 0–100 scale for easier interpre-
tation. PGDS of 100 represents an “optimal” power-speed genetic profile, 
that is, all GSs are 2. In contrast, PGDS of 0 represents the “worst” possi-
ble profile for power-speed genetic profile, that is, all GS’s are 0 (for more 
detailed description of the calculation see [6]. In the same way, we computed 
the EGDS5 based on 5 endurance genetic polymorphisms (PPARGC1A 
Gly482Ser, PPARA intron 7 G/C, PPARD T294C, NRF2 A/C, HIF C/T) 
[37]. We also computed a EGDS5/PGDS5 ratio, which represents the ath-
lete’s genetic tendency towards endurance or power events (Table 2).
The PGDS5 consists of five polymorphisms (ACTN3 C/T, ACE I/D, IL6 
–174 G/C, NOS3 T/, CAGT M/T) previously described as related to power 
performance [32]. The ACTN3 gene encodes for the synthesis of α-actinin-3 
in skeletal-muscle fibers, a sarcomeric protein necessary for producing 
powerful “explosive” contractions. A premature stop cod on polymorphism 
[Arg(R)577Ter(X)] in ACTN3 was first described by North et al. [29]. The 
absence of α-actinin-3 XX genotype is believed to induce top-level athletic 
performance in “pure” power and sprint sports [41]. In contrast, compared 
with the general population, the X allele is overrepresented in elite endur-
ance athletes [22, 41]. Mechanistic explanation for the latter finding might 
be found in the α-actinin-3 knockout (KO) mouse. Compared with wild-type 
mice, the muscles of the KO mouse exhibit 33% higher endurance and a shift 
towards increased activity of mitochondrial oxidative metabolism [23, 24].
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Table 1. Studied polymorphisms and genetic scores.
Symbol Gene Polymorphism Genotype
(2=’optimal’ 
genotype)
Endurance related genes
ACE
ACTN3
NRF2
Angiotensin converting enzyme
Alpha-actinin-3
Nuclear respiratory factor 2
I/D (rs1799752)
R/X  (rs1815739)
A/C (rs12594956)
0=DD, 1=ID, 2=II
0=RR, 1=RX, 2=XX
0=CC, 1=AC, 2=AA
PPARD Peroxisome prolifi lator- 
activated receptor delta
T294C (rs2016520) 0=TT, 1=CT, 2=CC
HIF Hypoxia Inducible Factor C/T (rs11549465) 0=CC, 1=CT, 2=TT
Power related genes
ACE Angiotensin converting enzyme I/D (rs1799752) 0=II, 1=ID, 2=DD
ACTN3 Alpha-actinin-3 R/X  (rs1815739) 0=XX, 1=RX, 2=RR
IL6 Interleukin-6 –174 G/C rs(1800795) 0=CC, 1=GC, 2=GG
NOS3 Endothelial nitric oxide synthase 3 –786 T>C rs(2070744) 0=CC, 1=TC, 2=TT
AGT Angiotensinogen        Met235Thr (rs699) 0 = TT, 1= TC, 2= CC
Other genes
ACSL A/G 
MCT1
MnSOD
IGF-I
Long-chain-fatty-acid–
CoA ligase 1 
mono carboxyla telactate trans-
porter 1
Mannose superoxide dismutase
Insulin-like growth factor-I
A1470T(rs1049434)
Val19Ala (rs1799725)
-C1245T (rs35767)
0 = AA, 1= AG, 2= GG
0 = TT, 1= AT, 2= AA
0 = VV, 1= AV, 2= AA
0 = CC, 1= CT, 2= TT
The ACE I/D polymorphism has been extensively studied with regard to 
exercise-related phenotypes. It is related to cardiovascular and skeletal mus-
cle function. An excess of the I allele has been associated with some aspects 
of endurance performance [34], probably by improvement in substrate 
delivery [39], skeletal muscle efficiency [38] and subsequent conservation 
of energy stores [26]. Conversely, an excess of the D allele has been reported 
among elite power-oriented athletes [27] in a mechanism that is most likely 
mediated by differences in skeletal muscle strength gain [17]. The IL6-174 
G/C polymorphism is associated with power sports performance, with the 
G allele exerting a favorable effect without an effect on endurance perfor-
mance [33]. This could be due to the G allele-associated improved muscle 
repair response after eccentric damage [40]. The NOS3 gene encodes NO 
synthase. The T786C polymorphism is associated with elite power sports 
performance, where the mutant C allele exerts favorable effect on power 
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performance through NO-mediated vasodilatation and muscle hypertro-
phy. Finally, the Met235Thr polymorphism of the AGT gene is associated 
with elite power sports performance, with the C allele exerting a favorable 
effect probably due to higher ANG II levels [18]. Overall, both ACE and 
AGT genes play a crucial role in the renin-angiotensin-aldosterone system, 
which modulates important cardiac and muscle phenotypes during exertion 
in humans.
Table 2.The athlete’s genetic polymorphisms and genetic scores.
Symbol Gene Polymorphism Genotype Score
(2=’optimal’ 
genotype)
Endurance related genes
ACE
ACTN3
NRF2
Angiotensin converting enzyme
Alpha-actinin-3
Nuclear respiratory factor 2
ID 
RX 
AC
1
1
1
PPARD Peroxisome prolifi lator-activated 
receptor delta
TC 1
HIF
EGDS5
Hypoxia Inducible Factor CC 0
40.8
Power related genes
ACE Angiotensin converting enzyme ID 1
ACTN3 Alpha-actinin-3 RX 1
IL6 Interleukin-6 CC 0
NOS3 Endothelial nitric oxide synthase 3 CC 0
AGT  Angiotensinogen          TC1
PGDS5 33.8
Other genes
ACSL A/G 
MCT1
MnSOD
IGF-I
Long-chain-fatty-acid–CoA ligase 1
monocarboxylatelactate transporter 1
Mannose superoxide dismutase
Insulin-like growth factor-I
AG
AT
AA
CC
1
1
2
0 
The EGDS5 consists of five polymorphisms (PPARGC1A Gly482Ser, PPARA 
intron 7 G/C, PPARD T294C, NRF2 A/C, HIF C/T), previously described 
as strongly related to endurance performance [37]. Of the five polymor-
phisms composing the EGDS5, four are related to mitochondrial biogenesis 
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[16]. Mitochondrial function is associated with aerobic performance. The 
peroxisome proliferator activated receptor (PPAR)-delta (gene PPARD) and 
PPAR-gamma co-activator 1 alpha (gene PPARGC1A) are determinants of 
mitochondrial function in animals and in vitro. PPAR-delta, in particular, 
regulates expression of genes involved in lipid and carbohydrate metabo-
lism, and affects insulin sensitivity and glucose uptake by skeletal muscles. A 
functional 294T/C polymorphism in this gene is associated with predisposi-
tion for endurance performance [1]. The nuclear respiratory factors NRF1 
and NRF2 coordinate the expression of nuclear and mitochondrial genes 
relevant to mitochondrial biogenesis and respiration. Carriers of a poly-
morphism in the sequence of translation initiator ATG in the NRF2 gene 
have a higher training response and improved running economy than non-
carriers, thus potentially explaining some of the inter-individual variance in 
endurance capacity [21]. In addition to the mitochondrial biogenesis related 
genes, hypoxia-induced factor (HIF) also contributes to athletic endurance 
performance. HIF-1 alpha is involved in acclimation to hypoxic stress, by 
up-regulating glycolysis and the angiogenesis response to low levels of tissue 
oxygenation. Some of the genes that are controlled by HIFs encode proteins 
that stimulate red cell production (mainly erythropoietin) [25].
In addition to the PGDS5 and EGDS5 other genetic polymorphisms were 
assessed. The Long-chain-fatty-acid–CoA ligase 1 (ACSL A/G) is an enzyme 
that in humans is encoded by the ACSL1 gene [35, 36]. Studies have shown 
that the AA polymorphism had lower VO2max responses to training than 
GG and A/G. This polymorphism explains 6.1% of the training-associated 
VO2max response [10].  
We also determined the SLC A1470T (MCT1) lactate proton-linked 
transporter polymorphism which mediates lactate transport across the sar-
coplasma. Both lactate influx into or efflux out of the muscle is increased 
when MCT1 is increased [9]. The AA genotype carriers have higher blood 
lactate levels compared to the TT and TA genotypes during different exer-
cise protocols [12].
We also assessed the MnSOD Val19Ala polymorphism. MnSOD is a 
mitochondrial enzyme catalyzing the conversion of superoxide radicals 
(O2•-) to hydrogen peroxide (H2O2) [2, 4]. The valine to alanine substitu-
tion affect the transport of MnSOD to the mitochondria. We recently dem-
onstrated [5] that the Ala allele was more frequent in both endurance and 
power-sprint athletes than in controls suggesting that the positive associa-
tion between the Ala allele and athletic performance may be related to ROS-
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related angiogenesis, mitochondria biosynthesis, and muscle hypertrophy, 
and not to MnSOD aerobic properties.
Finally, we determined the IGF-I -C1245T polymorphism. IGF-I plays a 
key role in exercise-associated muscle growth and development [3, 11, 13, 
19, 20, 28, 31]. Recently, we found that the presence of the rare TT genotype 
contributes to endurance performance, and in particular to power-speed 
athletic excellence in Israeli athletes [7].
DISCUSSION
The description of the training program of this athlete raises several unique 
and substantial issues. First, the athlete could not tolerate a transition from 
high-volume low-intensity training, that characterize the preparatory period 
of the training season, to the supra-intense training that characterize spe-
cific training required for a 400 m sprinter. Second, the athlete was able 
to achieve good results, and even personal records, following high-volume 
low-intensity training or when the total amount of training or the amount 
of high-intensity training was reduced. Third, despite very light resistance 
training, the athlete experienced confound delayed onset muscle soreness 
following these training sessions. Finally, the athlete refused to repeated 
recommendations of his coaches to change training focus and to specialize 
in middle distances like the 800 m run. In the following discussion we will 
present how genetic profiling could be used to address these points and to 
improve the overall training process. 
The coaches’ suggestion to make a transition to middle distance runs 
was based on their professional judgment of the athlete’s ability to better 
tolerate endurance-type training, and on the fact that his 100 m best result 
was not fast enough in order to achieve top 400 m performance. Despite 
the professional recommendation, the athlete refused to make the change, 
claiming inability to tolerate training and compete successfully in middle 
distances. We recently described the genetic scores of Israeli power/sprint 
athletes using a similar scoring model [8]. It was shown that the PGDS5 
score of the power/speed athletes was significantly higher than their EGDS5. 
Moreover, we calculated a threshold of PGDS5 and EGDS5, above which the 
probability of success in power/speed or endurance sport, increases substan-
tially, respectively. The case study athlete was the only power/speed athlete 
in the Israeli cohort with a higher EGDS5 than PGDS5 (Figure 1). Moreo-
ver, his EGDS5 was higher than the threshold for endurance success (40.8 
versus 34.8). A more careful look on his PGDS profile shows that in none of 
the five genes that consist the PGDS, he carried a power/speed promoting 
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polymorphism (a score of 2). Thus, although speculative, it is possible that 
knowledge of this genetic information at the time of training, in addition to 
the coaches’ professional impression and recommendation, could have com-
bined to change the athlete’s decision, and a transition to middle distance 
runs would have been made. 
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Figure 1. Power and endurance genetic distance scores (PGDF5 and EGDF5, 
respectively) of the case athlete compared to previously described Israeli sprinter 
cohort.
The only favoring genetic polymorphism that the athlete carried was the 
Mannose superoxide dismutase (MnSOD) Ala-Ala polymorphism. We 
recently reported that despite the important role of SOD in mitochondrial 
aerobic activity, the Ala-Ala polymorphism was found in both endurance 
and power/speed athletes [5]. Interestingly, the Ala-Ala polymorphism is 
associated with reduced mitochondrial processing efficiency and reduced 
transport of MnSOD into the mitochondria, and as a result, with decreased 
MnSOD efficiency against oxidative stress [2]. However, it was suggested 
that the positive association between the Ala allele and both endurance 
and power athletic performance may be related to Reactive Oxygen Species 
(ROS) related angiogenesis, mitochondrial biosynthesis, and muscle hyper-
trophy [5]. 
Another striking genetic finding was that the athlete was among the very 
few carriers of the IL-6 CC polymorphism. Recently, it was reported that the 
IL-6 G-174 C genotype is associated with CPK activity in a dose-dependent 
fashion [40]. Individuals with one or more of the C allele had reduced exer-
cise-associated IL-6 production, reduced post-exercise anti-inflammatory 
response, and as a result, higher post-exercise CPK peak, compared with 
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individuals homozygous for the G allele. The IL6 CC genotype was associ-
ated with a greater than threefold increased risk of a massive CPK response 
and a greater risk for exercise-induced rabdomyolysis [40]. The rare and 
unique existence of this polymorphism, in particularly combined with the 
MnSOD Ala-Ala polymorphism that promotes accumulation of oxygen 
radicals, may impose a significant limitation for athletic success. Moreover, 
it certainly may explain the athlete’s consistent difficulty to make a transi-
tion from high-volume to high-intensity training, the inadequate delayed 
onset muscle sourness response to light resistance training and the rather 
surprising ability to achieve good results and even personal records in times 
of reduced training intensity. The knowledge of this important genetic infor-
mation, at the time of training, could be used to a faster understanding of 
the distinct training limitations, and to a construction of a better individual-
ized training regimen. 
This illustrative case study shows both sides of genetic sports counseling. 
It should be noted that while a favorable or non-favorable genetic predispo-
sition is important, many other environmental and psychological factors, 
like coaching, training facilities, personal equipment, nutrition, familial sup-
port, motivation, and socioeconomic factors, are crucial for athletic success 
or failure. Furthermore, the potential use of genetic predisposition in very 
young athletes (e.g. at around age of 14 when selection of one sport activity 
is typically made), may raise some ethical issues. For example, how young 
athletes who lack aproper genetic profile, but are highly motivated to suc-
ceed would be treated? Should and how young athletes be told that they 
lack the “required” genetic profile to reach the top in their sport? The cur-
rent case study demonstrates that genetic discouragement is inappropriate, 
since despite a non-favorable PGDS, the athlete was able to march along the 
challenging, demanding and rewarding pathway of athletic training and to 
reach the peak in his sport by winning national championships and setting 
a national record. On the other hand, this illustrative case gives an example 
for the optional use of genetic assistance not only for sport selection, but 
also as an important piece in the complete puzzle picture of improving and 
optimizing training.  
Finally, this case study was chosen for several reasons. First, it gave us 
an exclusive opportunity to explore very specific training details and pre-
cise accompanying feelings during different training phases throughout 
an  athlete’s career. Moreover, we deliberately chose a national-level athlete, 
to show that genetic counseling should not be limited to top world-class 
 athletes. 
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